We are live on ! Find out more
ALT icon

Altimmune
ALT

143 hedge funds and large institutions have $389M invested in Altimmune in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

391% more capital invested

Capital invested by funds: $79.2M → $389M (+$310M)

124% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 25

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

66% more call options, than puts

Call options by funds: $32M | Put options by funds: $19.3M

28% more funds holding

Funds holding: 112 → 143 (+31)

6.79% more ownership

Funds ownership: 57.53% → 64.32% (+6.8%)

Holders
143
Holders Change
+31
Holders Change %
+27.68%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
56
Increased
41
Reduced
24
Closed
25
Calls
$32M
Puts
$19.3M
Net Calls
+$12.8M
Net Calls Change
+$11.5M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$17.4M
2
Morgan Stanley
Morgan Stanley
New York
+$6.67M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.2M
4
TIM
Timelo Investment Management
Ontario, Canada
+$3.25M
5
Invesco
Invesco
Georgia
+$2.98M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$7.18M
2
Marshall Wace
Marshall Wace
United Kingdom
-$7.15M
3
APM
Avidity Partners Management
Texas
-$3.02M
4
AAP
Ardsley Advisory Partners
Connecticut
-$2.72M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
126
Leonteq Securities AG
Switzerland
$3.38K +$1.25K +300 New
Fifth Third Bancorp
127
Fifth Third Bancorp
Ohio
$2.81K – – –
NMM
128
Naples Money Management
Florida
$2.81K +$1.04K +250 New
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$1.6K -$3.9K -934 -87%
Federated Hermes
130
Federated Hermes
Pennsylvania
$1.36K -$8.41K -2,014 -94%
Nisa Investment Advisors
131
Nisa Investment Advisors
Missouri
$1.27K – – –
CFGS
132
Concourse Financial Group Securities
Alabama
$1.13K – – –
HI
133
Harbour Investments
Wisconsin
$1.13K – – –
Northwestern Mutual Wealth Management
134
Northwestern Mutual Wealth Management
Wisconsin
$1.13K – – –
ASN
135
Advisory Services Network
Georgia
$1.13K +$418 +100 New
GRP
136
Global Retirement Partners
California
$1.08K +$418 +100 New
PA
137
Parallel Advisors
California
$450 – – –
WT
138
Whittier Trust
California
$270 +$100 +24 New
FFA
139
Farther Finance Advisors
California
$214 +$79 +19 New
FHA
140
First Horizon Advisors
Tennessee
$34 – – –
HNB
141
Huntington National Bank
Ohio
$23 – – –
TFG
142
Team Financial Group
California
$23 – – –
CPG
143
Cornerstone Planning Group
New Jersey
$11 – – –
APM
144
Avidity Partners Management
Texas
– -$3.02M -1,159,900 Closed
Balyasny Asset Management
145
Balyasny Asset Management
Illinois
– -$2.46M -947,578 Closed
Two Sigma Advisers
146
Two Sigma Advisers
New York
– -$2.44M -937,000 Closed
LCM
147
Laurion Capital Management
New York
– -$2.11M -809,685 Closed
Two Sigma Investments
148
Two Sigma Investments
New York
– -$1.74M -667,420 Closed
Prudential Financial
149
Prudential Financial
New Jersey
– -$866K -333,255 Closed
Renaissance Technologies
150
Renaissance Technologies
New York
– -$860K -330,900 Closed
3 4 5
6
7

ALT Hedge Fund Activity: Q4 2023 in Review

143 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2023, worth a combined $389M — up 391% from $79.2M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new ALT positions and 25 closed out — a net gain of 31 holders — while 41 added to existing stakes and 24 trimmed.

The largest buyer was Ameriprise, adding an estimated $17.4M. The largest seller was Nuveen, cutting an estimated $7.18M.

  • 143 institutional investors held Altimmune (ALT) as of Q4 2023, up from 112 in Q3 2023.
  • Funds reported $389M of Altimmune stock for Q4 2023, up 391% quarter-over-quarter.
  • 56 funds opened new Altimmune positions in Q4 2023 and 25 closed out, a net change of +31 holders.
  • The largest Altimmune buyer in Q4 2023 was Ameriprise, an estimated $17.4M added.
  • The largest Altimmune seller in Q4 2023 was Nuveen, an estimated $7.18M sold.

Based on aggregated 13F filings for Q4 2023.